News

Thermo Fisher Scientific and Arsenal Biosciences, Inc. (ArsenalBio) announced an update to our strategic collaboration to further the development of manufacturing processes for new…
Read More...

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, announced its entry into a royalty agreement with RTW Investments, LP and…
Read More...

Théa Open Innovation (“TOI”), a sister company of ophthalmic specialty pharmaceutical company Laboratoires Théa, and Galimedix Therapeutics, Inc. (“Galimedix”), a clinical-stage…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the European Commission (EC) approved Libtayo (cemiplimab) in combination with platinum-based chemotherapy for the first-line treatment of…
Read More...

Aquestive Therapeutics, Inc. announced it has expanded its exclusive license and supply agreement with Atnahs Pharma UK Limited (“Pharmanovia”), a global pharmaceutical company that…
Read More...

Regeneron Pharmaceuticals, Inc. and Sonoma Biotherapeutics, Inc. announced a collaboration to apply their scientific and clinical expertise and respective technology platforms to the…
Read More...

OncoVent Co., Ltd., a majority-controlled subsidiary of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (the "Company"), yesterday entered into a license agreement with Orient…
Read More...

Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement with Boehringer Ingelheim…
Read More...

Takeda Pharmaceutical Company Limited announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of Entyvio Pens for subcutaneous (SC) injection 108 mg /…
Read More...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced that a respiratory patient monitoring program using data from Teva’s Digihaler System has been…
Read More...

Thermo Fisher Scientific Inc., the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to…
Read More...

Cybeats Technologies Corp. is pleased to announce the commencement of a trial evaluation with one of the top-3 largest software companies by total revenue, for Cybeats SBOM Studio.…
Read More...

Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics announced that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics’ gene…
Read More...

Curia announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced the primary and all key secondary endpoints were met in a Phase 3 trial evaluating the investigational use of Dupixent (dupilumab)…
Read More...

AstraZeneca’s Calquence (acalabrutinib), a next generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been conditionally approved in China for the treatment of adult…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a worldwide drug discovery collaboration agreement with Macomics Ltd, a leader in macrophage drug discovery, to develop…
Read More...

Moderna, Inc. and Generation Bio Co. announced that the two companies have entered into a strategic collaboration to combine Moderna’s biological and technical expertise with core…
Read More...

Curia announced a collaboration with Corning Incorporated to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical…
Read More...

Ono Pharmaceutical Co., Ltd. announced that it has entered into a drug discovery collaboration agreement with MOLCURE Inc., to discover and develop innovative antibody drugs for…
Read More...